IINN Profile
Inspira Technologies Oxy B.H.N. Ltd., a specialized medical device company, is dedicated to advancing respiratory support technologies that offer non-invasive alternatives to traditional mechanical ventilation for patients experiencing respiratory failure. The company focuses on the research, development, manufacture, and marketing of its innovative respiratory support systems. Its flagship product, the Augmented Respiration Technology (ART) system, represents a significant advancement in respiratory care.
The ART system is designed to provide critical support to patients with declining oxygen saturation levels through a minimally invasive approach. It features a portable dual-lumen cannula that is inserted into the jugular vein, allowing for extracorporeal direct blood oxygenation. This method enhances and stabilizes oxygen levels without the need for invasive mechanical ventilation, potentially reducing complications associated with traditional ventilation methods.
In addition to its primary product, Inspira Technologies is engaged in ongoing research and development to expand its portfolio of respiratory support solutions. The company's technology aims to address the challenges faced by patients with severe respiratory conditions by providing a safer, more effective alternative to conventional ventilation systems. This approach aligns with the company's commitment to improving patient outcomes and advancing respiratory care.
Formerly known as Insense Medical Ltd., Inspira Technologies Oxy B.H.N. Ltd. rebranded in July 2020 to reflect its focus on innovative respiratory solutions. Founded in 2018 and headquartered in Ra'anana, Israel, the company continues to lead in the development of cutting-edge medical technologies designed to enhance patient care and support respiratory health globally.
|
